Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme.
作者信息
Eyre Toby A, Fox Christopher P, Boden Ali, Bloor Adrian, Dungawalla Moez, Shankara Paneesha, Went Richard, Schuh Anna H
机构信息
Department of Haematology, Oxford University Hospitals NHS Trust, Churchill Hospital, Oxford, UK.
Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
出版信息
Br J Haematol. 2019 Feb;184(4):667-671. doi: 10.1111/bjh.15151. Epub 2018 Feb 22.
PMID:29468637
Abstract
摘要
Zotero 插件